FPFS
SAGE

First Personal Financial Services’s Sage Therapeutics SAGE Stock Holding History

First Personal Financial Services’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-143
Closed -$26K – 714
2019
Q2 		$26K Hold
143
– – 0.01% 373
2019
Q1 		$23K Buy
143
+89
+165% +$12.9K 0.01% 382
2018
Q4 		$5K Buy
54
+15
+38% +$1.72K ﹤0.01% 564
2018
Q3 		$6K Hold
39
– – ﹤0.01% 576
2018
Q2 		$6K Sell
39
-7
-15% -$1.1K ﹤0.01% 557
2018
Q1 		$7K Buy
+46
New +$7.81K ﹤0.01% 869

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

First Personal Financial Services's SAGE Position: Q3 2019 in Review

First Personal Financial Services sold out of Sage Therapeutics (SAGE) in Q3 2019, closing a stake of 143 shares — an estimated $26K sold.

First Personal Financial Services first reported a position in SAGE in Q1 2018 and held it in 6 quarters. The position peaked at $26K in Q2 2019. 285 funds tracked by Wall St. Rank hold SAGE as of Q3 2019.

  • First Personal Financial Services reported no remaining Sage Therapeutics position as of Q3 2019 after selling out during the quarter.
  • First Personal Financial Services sold 143 Sage Therapeutics shares in Q3 2019, an estimated $26K.
  • First Personal Financial Services first reported a position in Sage Therapeutics in Q1 2018 and held it in 6 quarters.
  • First Personal Financial Services's Sage Therapeutics position peaked at $26K in Q2 2019.
  • 285 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2019.

Based on First Personal Financial Services's 13F filing for Q3 2019, filed 15 Oct 2019.